2018
DOI: 10.1073/pnas.1818150116
|View full text |Cite
|
Sign up to set email alerts
|

Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy

Abstract: SignificanceThis work shows that the amidated terminal ends of the secreted hypocretin (HCRT) peptides (HCRTNH2) are autoantigens in type 1 narcolepsy, an autoimmune disorder targeting HCRT neurons. The autoimmune process is usually initiated by influenza A flu infections, and a particular piece of the hemagglutinin (HA) flu protein of the pandemic 2009 H1N1 strain was identified as a likely trigger. This HA epitope has homology with HCRTNH2 and T cells cross-reactive to both epitopes are involved in the autoi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

12
148
2
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 165 publications
(168 citation statements)
references
References 59 publications
12
148
2
2
Order By: Relevance
“…A final question which we attempted to address is to explain the abundance of cross-reactive CTL against displayed pGR, pVIPR, or pLMP2 in B * 27:05 + individuals and the scarcity of such CTL in B * 27:09 + individuals (16). Molecular mimicry has been proven to exist in the HLA-B27 as well as other contexts (60,61) and may contribute also to the emergence of cross-reactive CTL in certain subtypes. It remains still unknown whether these cells do really play a decisive role in the development of HLA-B * 27-associated diseases (62).…”
Section: Discussionmentioning
confidence: 99%
“…A final question which we attempted to address is to explain the abundance of cross-reactive CTL against displayed pGR, pVIPR, or pLMP2 in B * 27:05 + individuals and the scarcity of such CTL in B * 27:09 + individuals (16). Molecular mimicry has been proven to exist in the HLA-B27 as well as other contexts (60,61) and may contribute also to the emergence of cross-reactive CTL in certain subtypes. It remains still unknown whether these cells do really play a decisive role in the development of HLA-B * 27-associated diseases (62).…”
Section: Discussionmentioning
confidence: 99%
“…The present study could not confirm humoural autoimmunity to any of the candidate antigens of the hypocretin transmitter system. Two recent studies found autoreactive Tcells against hypocretin peptides to be linked to NT1 [9,10]. Further studies are warranted to clarify if the immune response in NT1 is HLA DR rather than DQ-restricted [10] as well as if NT1-autoimmunity is restricted towards c-amidated but not against naive HCRT peptides [9].…”
Section: Discussionmentioning
confidence: 99%
“…The preprohypocretin and the hypocretin neuropeptides have been hypothesised as target autoantigens because of the autoimmune reaction directed towards hypocretin neurons. T-cell reactivity [9,10] but no autoantibodies have been demonstrated to hypocretin [11][12][13]. NT1-specific autoantibodies towards the Hypocretin receptor 2 (HCRT2R) have been investigated with conflicting results [14][15][16].…”
Section: Introductionmentioning
confidence: 99%
“…As for pMHC class II molecules on the other hand, it has been more challenging to develop efficient peptide exchange assays. However, Day et al were able to achieve peptide exchange for MHC class II molecules by thrombin‐cleavage of the peptide‐linker, a technique which also seems to work for some HLA‐DQ molecules but not all. Of note, techniques that improve the production efficacy of MHC class I and class II molecules, such as through in vivo biotinylation, have also been featured …”
Section: High‐throughput Production Of Pmhc Tetramersmentioning
confidence: 99%